Dangos 1 - 20 canlyniadau o 53 ar gyfer chwilio 'David D Ho', amser ymholiad: 0.04e Mireinio'r Canlyniadau
  1. 1
    A shot in the arm for AIDS vaccine research.

    A shot in the arm for AIDS vaccine research. gan David D Ho

    Cyhoeddwyd 2005-02-01
    Cael y testun llawn
    Erthygl
  2. 2
    Correction: A Shot in the Arm for AIDS Vaccine Research.

    Correction: A Shot in the Arm for AIDS Vaccine Research. gan David D Ho

    Cyhoeddwyd 2005-08-01
    Cael y testun llawn
    Erthygl
  3. 3
    Engineering multi-specific antibodies against HIV-1

    Engineering multi-specific antibodies against HIV-1 gan Neal N. Padte, Jian Yu, Yaoxing Huang, David D. Ho

    Cyhoeddwyd 2018-08-01
    Cael y testun llawn
    Erthygl
  4. 4
    In vivo expressed biologics for infectious disease prophylaxis: rapid delivery of DNA-based antiviral antibodies

    In vivo expressed biologics for infectious disease prophylaxis: rapid delivery of DNA-based antiviral antibodies gan Chasity D. Andrews, Yaoxing Huang, David D. Ho, Rachel A. Liberatore

    Cyhoeddwyd 2020-01-01
    Cael y testun llawn
    Erthygl
  5. 5
    An optimized thermodynamics integration protocol for identifying beneficial mutations in antibody design

    An optimized thermodynamics integration protocol for identifying beneficial mutations in antibody design gan Zizhang Sheng, Jude S. Bimela, Maple Wang, Zhiteng Li, Yicheng Guo, David D. Ho

    Cyhoeddwyd 2023-05-01
    Cael y testun llawn
    Erthygl
  6. 6
    Natural variation in Vif: differential impact on APOBEC3G/3F and a potential role in HIV-1 diversification.

    Natural variation in Vif: differential impact on APOBEC3G/3F and a potential role in HIV-1 diversification. gan Viviana Simon, Veronique Zennou, Deya Murray, Yaoxing Huang, David D Ho, Paul D Bieniasz

    Cyhoeddwyd 2005-09-01
    Cael y testun llawn
    Erthygl
  7. 7
    Impaired potency of neutralizing antibodies against cell–cell fusion mediated by SARS-CoV-2

    Impaired potency of neutralizing antibodies against cell–cell fusion mediated by SARS-CoV-2 gan Qian Wang, Andre Yanchen Yeh, Yicheng Guo, Hiroshi Mohri, Jian Yu, David D. Ho, Lihong Liu

    Cyhoeddwyd 2023-12-01
    Cael y testun llawn
    Erthygl
  8. 8
    Quantification of SARS‐CoV‐2 viral load in patients using time‐to‐results in antigen lateral flow tests

    Quantification of SARS‐CoV‐2 viral load in patients using time‐to‐results in antigen lateral flow tests gan Elsa W. Braunstein, Eric Vail, David D. Ho, Lihong Liu, Hiroshi Mohri, Matthew Gayhart, Glenn D. Braunstein

    Cyhoeddwyd 2024-02-01
    Cael y testun llawn
    Erthygl
  9. 9
    Robust SARS-CoV-2-neutralizing antibodies sustained through 6 months post XBB.1.5 mRNA vaccine booster

    Robust SARS-CoV-2-neutralizing antibodies sustained through 6 months post XBB.1.5 mRNA vaccine booster gan Qian Wang, Ian A. Mellis, Yicheng Guo, Carmen Gherasim, Riccardo Valdez, Aubree Gordon, David D. Ho, Lihong Liu

    Cyhoeddwyd 2024-09-01
    Cael y testun llawn
    Erthygl
  10. 10
    A recoding method to improve the humoral immune response to an HIV DNA vaccine.

    A recoding method to improve the humoral immune response to an HIV DNA vaccine. gan Yaoxing Huang, Michael Krasnitz, Raul Rabadan, Daniela M Witten, Yang Song, Arnold J Levine, David D Ho, Harlan Robins

    Cyhoeddwyd 2008-01-01
    Cael y testun llawn
    Erthygl
  11. 11
    Functional differences among the spike glycoproteins of multiple emerging severe acute respiratory syndrome coronavirus 2 variants of concern

    Functional differences among the spike glycoproteins of multiple emerging severe acute respiratory syndrome coronavirus 2 variants of concern gan Qian Wang, Manoj S. Nair, Saumya Anang, Shijian Zhang, Hanh Nguyen, Yaoxing Huang, Lihong Liu, David D. Ho, Joseph G. Sodroski

    Cyhoeddwyd 2021-11-01
    Cael y testun llawn
    Erthygl
  12. 12
    Functional properties of the spike glycoprotein of the emerging SARS-CoV-2 variant B.1.1.529

    Functional properties of the spike glycoprotein of the emerging SARS-CoV-2 variant B.1.1.529 gan Qian Wang, Saumya Anang, Sho Iketani, Yicheng Guo, Lihong Liu, Phinikoula S. Katsamba, Lawrence Shapiro, David D. Ho, Joseph G. Sodroski

    Cyhoeddwyd 2022-06-01
    Cael y testun llawn
    Erthygl
  13. 13
    Immunogenicity and protective efficacy of recombinant Clostridium difficile flagellar protein FliC

    Immunogenicity and protective efficacy of recombinant Clostridium difficile flagellar protein FliC gan Chandrabali Ghose, Ioannis Eugenis, Xingmin Sun, Adrianne N Edwards, Shonna M McBride, David T Pride, Ciarán P Kelly, David D Ho

    Cyhoeddwyd 2016-01-01
    Cael y testun llawn
    Erthygl
  14. 14
    2549 Characterizing the expression kinetics of HIV-1 envelope protein

    2549 Characterizing the expression kinetics of HIV-1 envelope protein gan Djin-Ye Oh, Lihong Liu, Benjamin Trinité, En-Wei Hu-Van Wright, Vincent Sahi, Yaoxing Huang, David N. Levy, David D. Ho

    Cyhoeddwyd 2018-06-01
    Cael y testun llawn
    Erthygl
  15. 15
    In Vivo Production of Monoclonal Antibodies by Gene Transfer via Electroporation Protects against Lethal Influenza and Ebola Infections

    In Vivo Production of Monoclonal Antibodies by Gene Transfer via Electroporation Protects against Lethal Influenza and Ebola Infections gan Chasity D. Andrews, Yang Luo, Ming Sun, Jian Yu, Arthur J. Goff, Pamela J. Glass, Neal N. Padte, Yaoxing Huang, David D. Ho

    Cyhoeddwyd 2017-12-01
    Cael y testun llawn
    Erthygl
  16. 16
    10E8V2.0/iMab: an engineered membrane-anchored bispecific anti-HIV antibody effective in preventing and treating HIV in humanized mice

    10E8V2.0/iMab: an engineered membrane-anchored bispecific anti-HIV antibody effective in preventing and treating HIV in humanized mice gan Anastasia Lanzi, Yaoxing Huang, Jian Yu, Xin Yao, Chasity D. Andrews, Lily Tsai, Mili R. Gajjar, Michael S. Seaman, Neal N. Padte, David D. Ho

    Cyhoeddwyd 2016-05-01
    Cael y testun llawn
    Erthygl
  17. 17
    Viral kinetics of sequential SARS-CoV-2 infections

    Viral kinetics of sequential SARS-CoV-2 infections gan Stephen M. Kissler, James A. Hay, Joseph R. Fauver, Christina Mack, Caroline G. Tai, Deverick J. Anderson, David D. Ho, Nathan D. Grubaugh, Yonatan H. Grad

    Cyhoeddwyd 2023-10-01
    Cael y testun llawn
    Erthygl
  18. 18
    Lead compounds for the development of SARS-CoV-2 3CL protease inhibitors

    Lead compounds for the development of SARS-CoV-2 3CL protease inhibitors gan Sho Iketani, Farhad Forouhar, Hengrui Liu, Seo Jung Hong, Fang-Yu Lin, Manoj S. Nair, Arie Zask, Yaoxing Huang, Li Xing, Brent R. Stockwell, Alejandro Chavez, David D. Ho

    Cyhoeddwyd 2021-04-01
    Cael y testun llawn
    Erthygl
  19. 19
    Evolving antibody evasion and receptor affinity of the Omicron BA.2.75 sublineage of SARS-CoV-2

    Evolving antibody evasion and receptor affinity of the Omicron BA.2.75 sublineage of SARS-CoV-2 gan Qian Wang, Zhiteng Li, Yicheng Guo, Ian A. Mellis, Sho Iketani, Michael Liu, Jian Yu, Riccardo Valdez, Adam S. Lauring, Zizhang Sheng, Aubree Gordon, Lihong Liu, David D. Ho

    Cyhoeddwyd 2023-11-01
    Cael y testun llawn
    Erthygl
  20. 20
    Author Correction: Lead compounds for the development of SARS-CoV-2 3CL protease inhibitors

    Author Correction: Lead compounds for the development of SARS-CoV-2 3CL protease inhibitors gan Sho Iketani, Farhad Forouhar, Hengrui Liu, Seo Jung Hong, Fang-Yu Lin, Manoj S. Nair, Arie Zask, Yaoxing Huang, Li Xing, Brent R. Stockwell, Alejandro Chavez, David D. Ho

    Cyhoeddwyd 2021-05-01
    Cael y testun llawn
    Erthygl

Offerynnau Chwilio: